Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Bahamas
Bahamas: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage was 90.0% in 2024. ◆ Volatile
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Bahamas, 2009–2024
Source: WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data. Measured in %.
Analysis
In 2024, pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Bahamas stood at 90.0%.
That represents a change of up 11.1% on the previous year and down 6.2% over ten years.
Over the whole period, pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Bahamas peaked at 97.0% in 2013 and was at its lowest, 1.0%, in 2010.
That places Bahamas 64th out of 146 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Bahamas, year by year
| Year | % | Change |
|---|---|---|
| 2009 | 3.0% | — |
| 2010 | 1.0% | -66.7% |
| 2011 | 1.0% | +0.0% |
| 2012 | 37.0% | +3600.0% |
| 2013 | 97.0% | +162.2% |
| 2014 | 96.0% | -1.0% |
| 2015 | 95.0% | -1.0% |
| 2016 | 94.0% | -1.1% |
| 2017 | 93.0% | -1.1% |
| 2018 | 90.0% | -3.2% |
| 2019 | 89.0% | -1.1% |
| 2020 | 83.0% | -6.7% |
| 2021 | 80.0% | -3.6% |
| 2022 | 79.0% | -1.2% |
| 2023 | 81.0% | +2.5% |
| 2024 | 90.0% | +11.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 3.0% | 3.0% | 3.0% | 1 |
| 2010s | 69.3% | 1.0% | 97.0% | 10 |
| 2020s | 82.6% | 79.0% | 90.0% | 5 |
Countries ranked near Bahamas
More health data for Bahamas
- Un projection of annual infant deaths, annual growth rate -11.11 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.0809 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,358 deaths per 1,000 people (2090)
- Number of infants who die before age 1 8 deaths (2100)
- Population ages 80 and above, female, per capita 0.0185 units per person (2025)
- Population ages 80 and above, male, annual growth rate 4.2 % change on previous year (2025)
- Population ages 80 and above, male, per unit of GDP 0 units per US$ of GDP (2024)
- Population ages 80 and above, male, per capita 0.0112 units per person (2025)
- Pertussis - number of reported cases, gaps filled 0 (2025)
- Pertussis - number of reported cases, per capita 0 units per person (2025)
Frequently asked questions
- What is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Bahamas?
- Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Bahamas was 90.0% in 2024, according to WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data.
- What is the highest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Bahamas?
- The highest recorded value was 97.0% in 2013.
- What is the lowest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Bahamas?
- The lowest recorded value was 1.0% in 2010.
- How does Bahamas rank for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Bahamas ranks 64th out of 146 countries with data for 2024.
- Is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage rising or falling in Bahamas?
- Over the last ten years it is down 6.2%. The long-run trend across the full record is volatile.
- Where does this Bahamas data come from?
- The figures come from WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as part of Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 16 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.